Warning letter
Old Hickory Medicine Company, Inc.: warning letter of Apr 21, 2004
FDA warning letter UCM146841 · New Orleans District Office
Key facts
| Reference number | UCM146841 |
|---|---|
| Company | Old Hickory Medicine Company, Inc. |
| Subject | Current Good Manufacturing Practice for Finished Pharmaceuticals/Misbranded/Adulterated |
| Issue date | Apr 21, 2004 |
| Posted date | Apr 21, 2004 |
| Issuing office | New Orleans District Office |
| Product type | Drugs |
| CFR sections cited | 201.66, 210, 211.22, 211.150, 333, 333.210, 344, 344.10, 344.50, 358, 358.510, 211.25(a) and 16 more |
| Country | 3 |
| Inspection city | Andalusia |
| Inspection ZIP | 36420 |
| Inspection start date | Nov 18, 2003 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: